Penumbra Inc (PEN) - Total Liabilities

Latest as of September 2025: $385.67 Million USD

Based on the latest financial reports, Penumbra Inc (PEN) has total liabilities worth $385.67 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Penumbra Inc generate cash to assess how effectively this company generates cash.

Penumbra Inc - Total Liabilities Trend (2013–2024)

This chart illustrates how Penumbra Inc's total liabilities have evolved over time, based on quarterly financial data. Check Penumbra Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Penumbra Inc Competitors by Total Liabilities

The table below lists competitors of Penumbra Inc ranked by their total liabilities.

Company Country Total Liabilities
Solstice Advanced Materials, Inc
NASDAQ:SOLS
USA $4.30 Billion
Fox Corp Class B
NASDAQ:FOX
USA $10.35 Billion
Sinopac Financial Holdings Co Ltd
TW:2890
Taiwan NT$2.86 Trillion
VERBUND AG
VI:VER
Austria €7.33 Billion
Synnex Corporation
NYSE:SNX
USA $25.80 Billion
McCormick & Company Incorporated
NYSE:MKC
USA $7.43 Billion
KT&G Corp
KO:033780
Korea ₩5.61 Trillion
COLOPLAST SP.ADR 1/10 DK1
F:CBH
Germany €34.99 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Penumbra Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Penumbra Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 6.73 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 1.89 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.28 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.22 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Penumbra Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Penumbra Inc (2013–2024)

The table below shows the annual total liabilities of Penumbra Inc from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 $382.25 Million +1.30%
2023-12-31 $377.36 Million +1.43%
2022-12-31 $372.03 Million +28.14%
2021-12-31 $290.32 Million +56.77%
2020-12-31 $185.19 Million +2.72%
2019-12-31 $180.29 Million +94.71%
2018-12-31 $92.59 Million +21.42%
2017-12-31 $76.26 Million +82.84%
2016-12-31 $41.71 Million +33.14%
2015-12-31 $31.33 Million -76.58%
2014-12-31 $133.75 Million +68.86%
2013-12-31 $79.21 Million --

About Penumbra Inc

NYSE:PEN USA Medical Devices
Market Cap
$12.76 Billion
Market Cap Rank
#1842 Global
#683 in USA
Share Price
$325.33
Change (1 day)
-0.35%
52-Week Range
$225.54 - $359.40
All Time High
$359.40
About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also… Read more